Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in Can J Cardiol Retrieve available abstracts of 144 articles: HTML format

Single Articles

April 2024
1. ROBERT YAO RJ, Fordyce CB
   Optimal transfusion threshold for anemic patients presenting with myocardial infarction and heart failure: dream or REALITY?
   Can J Cardiol. 2024 Apr 9:S0828-282X(24)00299-X. doi: 10.1016/j.cjca.2024.
   PubMed    
   
   
   
2. COURTNEY BK
   Very Late Stent Thrombosis in Japan: A Look Into the Future?
   Can J Cardiol. 2024;40:705-706.
   PubMed    
   
   
   
3. REA ABBAC, Mihajlovic V, Vishram-Nielsen JKK, Brahmbhatt DH, et al
   Pulmonary Artery Catheter Usage and Impact on Mortality in Patients With Cardiogenic Shock: Results From a Canadian Single-Centre Registry.
   Can J Cardiol. 2024;40:664-673.
   PubMed     Abstract available
   
   
   
4. MORI H, Sekimoto T, Arai T, Sakai R, et al
   Mechanisms of Very Late Stent Thrombosis in Japanese Patients as Assessed by Optical Coherence Tomography.
   Can J Cardiol. 2024;40:696-704.
   PubMed     Abstract available
   
   
   
5. DESSUREAULT A, Massie E, Fish D, Parent MC, et al
   Cardiomyopathy and Cardiogenic Shock Caused by Juvenile Hemochromatosis Improving With Guideline-Directed Medical Therapy Despite High Ferritin Levels.
   Can J Cardiol. 2024;40:662-663.
   PubMed    
   
   
   
6. AMJAD M
   High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery.
   Can J Cardiol. 2024;40:734.
   PubMed    
   
   
   
7. GUERRA PG, Simpson CS, Van Spall HGC, Asgar AW, et al
   Canadian Cardiovascular Society 2023 Guidelines on the Fitness to Drive.
   Can J Cardiol. 2024;40:500-523.
   PubMed     Abstract available
   
   
   March 2024
8. AKIOYAMEN LE, Ko DT, Cram P, Landon BE, et al
   Approaches to comparing the impact of socioeconomic disadvantage on acute myocardial infarction care within and across countries: a Scoping review.
   Can J Cardiol. 2024 Mar 26:S0828-282X(24)00274.
   PubMed     Abstract available
   
   
   
9. SAADA M, Lavi S
   Angiography-Derived Index of Microvascular Resistance: A New Frontier in the Management of Patients With Coronary Artery Disease.
   Can J Cardiol. 2024;40:444-446.
   PubMed    
   
   
   
10. CHEN L, Sang C, Wu Y, Chen W, et al
    Coronary Angiography-Derived Index of Microcirculatory Resistance Associated With New-Onset Atrial Fibrillation in Patients With STEMI.
    Can J Cardiol. 2024;40:434-443.
    PubMed     Abstract available
    
    
    
11. SHOWKATHALI R, Yalamanchi RP, Kumar AM, Cs V, et al
    Isolated Giant Right Coronary Aneurysm Associated With IgG4-Related Disease.
    Can J Cardiol. 2024;40:447-449.
    PubMed    
    
    
    February 2024
12. DUCROCQ G, Cachanado M, Simon T, Puymirat E, et al
    Restrictive vs Liberal Blood Transfusions for Patients with Acute Myocardial Infarction and Anaemia by Heart Failure Status: An RCT Subgroup Analysis.
    Can J Cardiol. 2024 Feb 24:S0828-282X(24)00179.
    PubMed     Abstract available
    
    
    
13. VERVOORT D, Sud M, Zeis TM, Haouzi AA, et al
    Do the Few Dictate Care for the Many? Revascularisation Considerations That Go Beyond the Guidelines.
    Can J Cardiol. 2024;40:275-289.
    PubMed     Abstract available
    
    
    
14. BAINEY KR, Marquis-Gravel G, Belley-Cote E, Turgeon RD, et al
    Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology 2023 Focused Update of the Guidelines for the Use of Antiplatelet Therapy.
    Can J Cardiol. 2024;40:160-181.
    PubMed     Abstract available
    
    
    
15. DEL PORTILLO JH, Farjat-Pasos J, Galhardo A, Avvedimento M, et al
    Aortic Stenosis With Coronary Artery Disease: SAVR or TAVR-When and How?
    Can J Cardiol. 2024;40:218-234.
    PubMed     Abstract available
    
    
    January 2024
16. SCHMITZ T, Harmel E, Raake P P, Freuer D, et al
    Association between acute myocardial infarction symptoms and short- and long-term mortality after the event.
    Can J Cardiol. 2024 Jan 24:S0828-282X(24)00067.
    PubMed     Abstract available
    
    
    
17. JOHNSTON AM, Yiu CHK, Reilly S
    Decoding Long Non-coding RNAs in Myocardial Infarction: A Step Closer to a 'Magic Bullet'?
    Can J Cardiol. 2024 Jan 21:S0828-282X(24)00044.
    PubMed    
    
    
    
18. ROULE V, Beygui F, Cayla G, Range G, et al
    P2Y(12) Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial Necrosis.
    Can J Cardiol. 2024;40:31-39.
    PubMed     Abstract available
    
    
    December 2023
19. HEMETSBERGER R, Mankerious N, Muntane-Carol G, Temporal J, et al
    In-hospital Outcomes of Rotational Atherectomy in ST-elevation Myocardial Infarction - Results from the Multicenter ROTA-STEMI Network.
    Can J Cardiol. 2023 Dec 24:S0828-282X(23)02034.
    PubMed     Abstract available
    
    
    
20. WANG S, Xuan L, Hu X, Sun F, et al
    LncRNA CCRR Attenuates Post-Myocardial Infarction Inflammatory Response by Inhibiting the TLR Signaling Pathway.
    Can J Cardiol. 2023 Dec 9:S0828-282X(23)01973-6. doi: 10.1016/j.cjca.2023.
    PubMed     Abstract available
    
    
    
21. RUEL M, Gupta S, Ponnambalam M, Chong AY, et al
    Less Invasive and Hybrid Surgical / Interventional Coronary Disease Management: The Future is Now.
    Can J Cardiol. 2023 Dec 7:S0828-282X(23)01970-0. doi: 10.1016/j.cjca.2023.
    PubMed     Abstract available
    
    
    November 2023
22. WELSH RC
    Antiplatelet pretreatment prior to angiography with anticipated or planned Percutaneous Coronary Intervention in Stable Ischemic Heart Disease.
    Can J Cardiol. 2023 Nov 25:S0828-282X(23)01947.
    PubMed    
    
    
    
23. HU P, Chang J, Huang Y, Guo M, et al
    Nonoptimum Temperatures Are More Closely Associated With Fatal Myocardial Infarction Than With Nonfatal Events.
    Can J Cardiol. 2023 Nov 3:S0828-282X(23)01645-8. doi: 10.1016/j.cjca.2023.
    PubMed     Abstract available
    
    
    
24. ALKASAB M, Bainey KR
    Clopidogrel Monotherapy in Older Stable Ischemic Heart Disease Patients Receiving Percutaneous Coronary Intervention: A Paradigm Shiftt?
    Can J Cardiol. 2023 Nov 2:S0828-282X(23)01875-5. doi: 10.1016/j.cjca.2023.
    PubMed    
    
    
    
25. QIU M, Yan W, Liu M
    YAP Facilitates NEDD4L-Mediated Ubiquitination and Degradation of ACSL4 to Alleviate Ferroptosis in Myocardial Ischemia-Reperfusion Injury.
    Can J Cardiol. 2023;39:1712-1727.
    PubMed     Abstract available
    
    
    
26. HOSSEINI F, Franco C, Whalen BA, Taylor CM, et al
    Increased Classical Monocytes in South Asian Compared With White Caucasian Individuals at Risk for Coronary Atherosclerosis.
    Can J Cardiol. 2023;39:1584-1586.
    PubMed    
    
    
    
27. GODOY LC, Ko DT, Farkouh ME, Shah BR, et al
    Dealing With Nonproportional Hazards in Coronary Revascularisation Studies.
    Can J Cardiol. 2023;39:1651-1660.
    PubMed     Abstract available
    
    
    
28. MARQUIS-GRAVEL G, Samuel M
    Can We Define the Role of Cardiac Stress Testing After Percutaneous Coronary Intervention With the Use of Observational Data?
    Can J Cardiol. 2023;39:1522-1524.
    PubMed    
    
    
    
29. MINTZ GS
    Periprocedural Myocardial Injury: We Can Predict It, But Can We Prevent It?
    Can J Cardiol. 2023;39:1510-1512.
    PubMed    
    
    
    
30. BAGAI A, Madan M, Overgaard C, Porter J, et al
    Long-term Clinical Outcomes Following Cardiac Stress Testing After Percutaneous Coronary Intervention.
    Can J Cardiol. 2023;39:1513-1521.
    PubMed     Abstract available
    
    
    
31. IRIE D, Matsumoto H, Isodono K, Higuchi S, et al
    Complementary Roles of Near-Infrared Spectroscopy and Intravascular Ultrasound in the Prediction of Periprocedural Myocardial Injury.
    Can J Cardiol. 2023;39:1502-1509.
    PubMed     Abstract available
    
    
    
32. VAN DAMME A, McDermott S, McMurtry S, Kung JY, et al
    Secondary Prevention and Rehabilitation for Spontaneous Coronary Artery Dissection: A Systematic Review.
    Can J Cardiol. 2023;39.
    PubMed     Abstract available
    
    
    October 2023
33. GABA P, Bhatt DL
    Promise of a Novel Classification System for Acute Myocardial Infarction.
    Can J Cardiol. 2023 Oct 29:S0828-282X(23)01839.
    PubMed    
    
    
    
34. KUMAR A, Connelly K, Vora K, Bainey KR, et al
    The Canadian Cardiovascular Society Classification of Acute Atherothrombotic Myocardial Infarction Based on Stages of Tissue Injury Severity: An Expert Consensus Statement.
    Can J Cardiol. 2023 Oct 26:S0828-282X(23)01735.
    PubMed     Abstract available
    
    
    
35. STEG PG, Szarek M, Valgimigli M, Islam S, et al
    Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome.
    Can J Cardiol. 2023;39:1315-1324.
    PubMed     Abstract available
    
    
    September 2023
36. LEE K, Kang J, Park KW, Park TH, et al
    Impact of Age on Antiplatelet Monotherapy in the Chronic Maintenance Period After PCI: A Post-hoc Analysis from the HOST-EXAM Extended Study.
    Can J Cardiol. 2023 Sep 22:S0828-282X(23)01736.
    PubMed     Abstract available
    
    
    
37. ALTER DA, Rosenfeld A, Fang J, Ko DT, et al
    THE RELATIONSHIP BETWEEN RESIDENTIAL MOBILITY AND MORTALITY FOLLOWING ACUTE MYOCARDIAL INFARCTION.
    Can J Cardiol. 2023 Sep 17:S0828-282X(23)01667.
    PubMed     Abstract available
    
    
    August 2023
38. ISIDORO CA, Deniset JF
    Pericardial Immune Cells and Their Evolving Role in Cardiovascular Pathophysiology.
    Can J Cardiol. 2023;39:1078-1089.
    PubMed     Abstract available
    
    
    July 2023
39. WEN KOH TJ, Hwee Tan HJ, Joseph Ravi PR, Sng JW, et al
    Association between breast arterial calcifications and cardiovascular disease: a systematic review and meta-analysis.
    Can J Cardiol. 2023 Jul 26:S0828-282X(23)01560.
    PubMed     Abstract available
    
    
    
40. HEO RH, Wang MK, Meyre PB, Birchenough L, et al
    Associations of inflammatory biomarkers with the risk of morbidity and mortality after cardiac surgery: a systematic review and meta-analysis.
    Can J Cardiol. 2023 Jul 24:S0828-282X(23)01557.
    PubMed     Abstract available
    
    
    
41. HIRAO Y, Seki T, Watanabe N, Matoba S, et al
    Health-related Quality of Life after Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: a systematic review and meta-analysis.
    Can J Cardiol. 2023 Jul 6:S0828-282X(23)01471-X. doi: 10.1016/j.cjca.2023.
    PubMed     Abstract available
    
    
    
42. KAVSAK PA, Jaffe AS
    Troponin T Levels and When to Peek Using CMR in Patients With MINOCA.
    Can J Cardiol. 2023;39:945-946.
    PubMed    
    
    
    
43. KAVSAK PA, Clark L, Arnoldo S, Lou A, et al
    Analytic Result Variation for High-Sensitivity Cardiac Troponin: Interpretation and Consequences.
    Can J Cardiol. 2023;39:947-951.
    PubMed    
    
    
    
44. MUMTAZ M, Downar E, Kawada S, Zammit-Burg M, et al
    Utility of Substrate Mapping Using Extrasystole to Localise Comprehensive Ventricular Tachycardia Circuits: Results From Intra-operative Mapping Studies.
    Can J Cardiol. 2023;39:912-921.
    PubMed     Abstract available
    
    
    
45. LIM PO
    Do Panic Attacks Causes Coronary Microvascular Spasm?
    Can J Cardiol. 2023;39:970.
    PubMed    
    
    
    June 2023
46. LIN J, Harahsheh AS, Raghuveer G, Jain S, et al
    Emerging Insights Into the Pathophysiology of Multisystem Inflammatory Syndrome Associated With COVID-19 in Children.
    Can J Cardiol. 2023;39:793-802.
    PubMed     Abstract available
    
    
    May 2023
47. TOMURA N, Sawada K, Noguchi T
    A challenging case of myocardial infarction with nonobstructive coronary arteries worsened by early provocative testing.
    Can J Cardiol. 2023 May 27:S0828-282X(23)00439.
    PubMed    
    
    
    
48. MANTZOURANIS E, Leontsinis I, Sakalidis A, Soulaidopoulos S, et al
    Taking a Deep Dive Into MINOCA.
    Can J Cardiol. 2023;39:611-613.
    PubMed    
    
    
    
49. ARIAS-MENDOZA A, Gonzalez-Pacheco H, Gopar-Nieto R, Damas-de Los Santos F, et al
    Simultaneous Presentation of Spontaneous Coronary Artery Dissection and Acute Type B Aortic Dissection in the Puerperium.
    Can J Cardiol. 2023;39:678-680.
    PubMed    
    
    
    April 2023
50. YU C, Meier S, Bestrawos D, Sun D, et al
    Role of cardiac magnetic resonance imaging and troponin-T in definitive diagnosis of Myocardial Infarction with Non-obstructive Coronary Arteries (MINOCA).
    Can J Cardiol. 2023 Apr 18:S0828-282X(23)00310.
    PubMed     Abstract available
    
    
    
51. BERDAJS D, Miazza J, Koechlin L, Gahl B, et al
    Minimally invasive non-resectional mitral valve repair long-term results.
    Can J Cardiol. 2023 Apr 14:S0828-282X(23)00306.
    PubMed     Abstract available
    
    
    
52. FERRON M, Merlet N, Mihalache-Avram T, Mecteau M, et al
    Adcy9 gene inactivation improves cardiac function after myocardial infarction in mice.
    Can J Cardiol. 2023 Apr 11:S0828-282X(23)00305.
    PubMed     Abstract available
    
    
    
53. SINGER Z, Nagpal D, Slessarev M, Durocher D, et al
    The Utility of Invasive Hemodynamics in the Management of Cardiogenic Shock.
    Can J Cardiol. 2023;39:420-422.
    PubMed    
    
    
    
54. KANAOKA K, Iwanaga Y, Nakai M, Nishioka Y, et al
    Hospital- and Patient-Level Analysis of Quality Indicators in Acute Coronary Syndrome Care: A Nationwide Database Study.
    Can J Cardiol. 2023;39:515-523.
    PubMed     Abstract available
    
    
    
55. ROSTON TM, So DY, Liu S, Fordyce CB, et al
    Leveraging Existing STEMI Networks to Regionalize Cardiogenic Shock Systems of Care: Efforts to Expand the Scope Could Improve Shock Outcomes.
    Can J Cardiol. 2023;39:427-431.
    PubMed    
    
    
    
56. JUNG RG, Di Santo P, Mathew R, Simard T, et al
    Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
    Can J Cardiol. 2023;39:394-402.
    PubMed     Abstract available
    
    
    
57. JENTZER JC, Hernandez-Montfort J
    Refining the Stratification and Prognosis of Cardiogenic Shock Patients to Improve Their Outcome.
    Can J Cardiol. 2023;39:423-426.
    PubMed    
    
    
    March 2023
58. ISATH A, Malik A, Bandyopadhyay D, Goel A, et al
    Effect of COVID-19 Infection in Patients Presenting with Acute Myocardial Infarction and Cardiogenic Shock.
    Can J Cardiol. 2023 Mar 10:S0828-282X(23)00209.
    PubMed    
    
    
    
59. DUCEPPE E, Borges FK, Tiboni M, Pearse R, et al
    High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery: A Cohort Study.
    Can J Cardiol. 2023;39:311-318.
    PubMed     Abstract available
    
    
    
60. TULLOCH H, Bouchard K, Brownrigg J, Coutinho T, et al
    Depression and Anxiety Before and After Cardiac Rehabilitation: Comparing Patients With and Without Spontaneous Coronary Artery Dissection.
    Can J Cardiol. 2023;39:350-352.
    PubMed    
    
    
    
61. GOUDA P, Graham MM
    Detection of Myocardial Injury After Noncardiac Surgery: Levelling the Troponin Playing Field.
    Can J Cardiol. 2023;39:319-320.
    PubMed    
    
    
    February 2023
62. BRENES-CASTRO DA, Toledo Aleman EL, Bolanos JA, Araujo VT, et al
    Coronary Artery Vasculitis as a Substrate for Myocardial Infarction in a Patient with Systemic Lupus Erythematosus.
    Can J Cardiol. 2023 Feb 27:S0828-282X(23)00149.
    PubMed     Abstract available
    
    
    January 2023
63. BARNETT CF, Brusca SB, Hanff TC, Blumer V, et al
    Management of Cardiogenic Shock Unrelated to Acute Myocardial Infarction.
    Can J Cardiol. 2023 Jan 30:S0828-282X(23)00069.
    PubMed     Abstract available
    
    
    
64. WANG YL, Ma XX, Zhu H, Bai L, et al
    T cell Mineralocorticoid Receptor Deficiency Attenuates Pathological Ventricular Remodeling After Myocardial Infarction.
    Can J Cardiol. 2023 Jan 17:S0828-282X(23)00050.
    PubMed     Abstract available
    
    
    
65. O'RIELLY CM, Harrison TG, Andruchow JE, Ronksley PE, et al
    Risk scores for clinical risk stratification of emergency department patients with chest pain but no acute myocardial infarction: A systematic review.
    Can J Cardiol. 2023 Jan 11:S0828-282X(23)00043.
    PubMed     Abstract available
    
    
    
66. PATEL S, Fung M, Liang Z, Butalia S, et al
    Temporal Trends of the Prevalence of Angina With No Obstructive Coronary Artery Disease (ANOCA).
    Can J Cardiol. 2023;39:63-70.
    PubMed     Abstract available
    
    
    
67. WU SJ, He RL, Zhao L, Yu XY, et al
    Cardiac-Specific Overexpression of Caveolin-1 in Rats With Ischemic Cardiomyopathy Improves Arrhythmogenicity and Cardiac Remodelling.
    Can J Cardiol. 2023;39:73-86.
    PubMed     Abstract available
    
    
    
68. IRFAN S, McCarthy M, Miner S
    Association Between Panic Attack and Coronary Ischemia Due to Reduction in Coronary Blood Flow.
    Can J Cardiol. 2023;39:71-72.
    PubMed    
    
    
    December 2022
69. MAEDA M, Isawa T, Hirose S, Honda S, et al
    Congenital absence of left coronary artery ostium in a patient presenting with anterior ST-elevation myocardial infarction.
    Can J Cardiol. 2022 Dec 27:S0828-282X(22)01115.
    PubMed    
    
    
    
70. UDELL JA, Brickman AR, Chu A, Ferreira-Legere LE, et al
    Primary Care Clinical Volumes, Cholesterol Testing, and Cardiovascular Outcomes.
    Can J Cardiol. 2022 Dec 24:S0828-282X(22)01112.
    PubMed     Abstract available
    
    
    
71. KIM I, Field TS, Wan D, Humphries K, et al
    Sex and Gender Bias as a Mechanistic Determinant of Cardiovascular Disease Outcomes.
    Can J Cardiol. 2022;38:1865-1880.
    PubMed     Abstract available
    
    
    
72. INOHARA T, McAlister C, Samuel R, Starovoytov A, et al
    Differences in Revascularization Strategy and Outcomes by Clinical Presentations in Spontaneous Coronary Artery Dissection.
    Can J Cardiol. 2022;38:1935-1943.
    PubMed     Abstract available
    
    
    November 2022
73. RANDHAWA VK, Kim D, Arora R, Moussa F, et al
    Did we "OBTAIN" new insights for optimal timing of CABG and survival after acute myocardial infarction?
    Can J Cardiol. 2022 Nov 22:S0828-282X(22)01042.
    PubMed    
    
    
    
74. HUMPHRIES KH, Norris CM, Pilote L
    Sex Differences in Acute Myocardial Infarction: Good News and Bad News.
    Can J Cardiol. 2022;38:1661-1663.
    PubMed    
    
    
    
75. MADAN M, Qiu F, Sud M, Graham MM, et al
    Clinical Outcomes in Younger Women Hospitalized With an Acute Myocardial Infarction: A Contemporary Population-Level Analysis.
    Can J Cardiol. 2022;38:1651-1660.
    PubMed     Abstract available
    
    
    
76. SKALIDIS I, Muller O, Fournier S, Antiochos P, et al
    Feasibility of Using the Metaverse as Telecardiology Platform: Remote Follow-up of a Patient With Vasospastic Angina.
    Can J Cardiol. 2022;38:1768-1769.
    PubMed    
    
    
    
77. KURUP R, Ybarra LF
    Successful Percutaneous Retrieval of a Fractured Trapliner Guide Extension Catheter Lodged Within a Radial Bypass Graft.
    Can J Cardiol. 2022;38:1770-1772.
    PubMed    
    
    
    
78. SO DYF, Bagai A, van Diepen S, Fordyce CB, et al
    A Pan-Canadian Survey of Cardiogenic Shock Management: A Report From the Canadian Cardiovascular Research Collaboratory (C3) Cardiogenic Shock Working Group.
    Can J Cardiol. 2022;38:1732-1735.
    PubMed    
    
    
    
79. PIRZADA A, Hayami D
    Stress Echocardiography in the Diagnosis of Coronary Microvascular Ischemia: The Forgotten Old Faithful Tool?
    Can J Cardiol. 2022;38:1763-1765.
    PubMed    
    
    
    October 2022
80. FERNANDES GC, Kovacs R, Abbott JD, Subacius H, et al
    Determinants of Early and Late In-Hospital Mortality After Acute Myocardial Infarction A Sub-analysis of the OBTAIN Registry.
    Can J Cardiol. 2022 Oct 20. pii: S0828-282X(22)00978.
    PubMed     Abstract available
    
    
    
81. KAVSAK PA, Cerasuolo JO, Hewitt MK, Mondoux SE, et al
    Identifying very low risk patients for future myocardial infarction or death.
    Can J Cardiol. 2022 Oct 15. pii: S0828-282X(22)00970.
    PubMed    
    
    
    
82. PACHECO C, Luu J, Mehta PK, Wei J, et al
    INOCA and MINOCA: Are Women's Heart Centres the Answer to Understanding and Management of These Increasing Populations of Women (and Men)?
    Can J Cardiol. 2022;38:1611-1614.
    PubMed    
    
    
    
83. PARVAND M, Cai L, Ghadiri S, Humphries KH, et al
    One-Year Prospective Follow-up of Women With INOCA and MINOCA at a Canadian Women's Heart Centre.
    Can J Cardiol. 2022;38:1600-1610.
    PubMed     Abstract available
    
    
    
84. MURAI K, Kataoka Y, Nicholls SJ, Puri R, et al
    The Residual Lipid-Rich Coronary Atheroma Behind the Implanted Newer-Generation Drug-Eluting Stent and Future Stent-Related Event Risks.
    Can J Cardiol. 2022;38:1504-1515.
    PubMed     Abstract available
    
    
    
85. PICARD F, Pighi M, Marquis-Gravel G, Labinaz M, et al
    The Ongoing Saga of the Evolution of Percutaneous Coronary Intervention: From Balloon Angioplasty to Recent Innovations to Future Prospects.
    Can J Cardiol. 2022;38.
    PubMed     Abstract available
    
    
    
86. LANDI A, Branca M, Vranckx P, Leonardi S, et al
    Radial vs Femoral Access in ACS Patients Undergoing Complex PCI Is Associated With Consistent Bleeding Benefit and No Excess of Risks.
    Can J Cardiol. 2022;38:1488-1500.
    PubMed     Abstract available
    
    
    
87. HAYEK A, Ly HQ, Avram R
    Hitting the Rock Behind the Metal: Is Intravascular Lithotripsy for In-Stent Percutaneous Coronary Intervention the Perfect Symphony?
    Can J Cardiol. 2022;38:1476-1477.
    PubMed    
    
    
    
88. LIU H, Southern DA, Arena R, Sajobi T, et al
    Cardiac Rehabilitation and Risk of Incident Atrial Fibrillation in Patients With Coronary Artery Disease.
    Can J Cardiol. 2022;38:1621-1628.
    PubMed     Abstract available
    
    
    
89. PHAM V, Bonnet M, Varenne O, Lafont A, et al
    In-Stent Use of Intravascular Coronary Lithotripsy for Restenosis and Stent Underexpansion: A Multicentre Experience.
    Can J Cardiol. 2022;38:1474-1475.
    PubMed    
    
    
    
90. BALDETTI L, Gallone G, Sacchi S, Pazzanese V, et al
    Mechanical Circulatory Support Weaning With Angiotensin Receptor-Neprilysin Inhibitor in Cardiogenic Shock.
    Can J Cardiol. 2022;38:1539-1541.
    PubMed    
    
    
    
91. HOSSEINI F, Malhi N, Sellers SL, Khan N, et al
    The Morphology of Coronary Artery Disease in South Asians vs White Caucasians and Its Implications.
    Can J Cardiol. 2022;38:1570-1579.
    PubMed     Abstract available
    
    
    
92. MARQUIS-GRAVEL G, Robert-Halabi M, Bainey KR, Tanguay JF, et al
    The Evolution of Antiplatelet Therapy After Percutaneous Coronary Interventions: A 40-Year Journey.
    Can J Cardiol. 2022;38.
    PubMed     Abstract available
    
    
    
93. STRAUSS BH, Tanguay JF, Picard F, Doucet S, et al
    Coronary Stenting: Reflections on a 35-Year Journey.
    Can J Cardiol. 2022;38.
    PubMed     Abstract available
    
    
    
94. YBARRA LF, Rinfret S
    Why and How Should We Treat Chronic Total Occlusion? Evolution of State-of-the-Art Methods and Future Directions.
    Can J Cardiol. 2022;38.
    PubMed     Abstract available
    
    
    September 2022
95. LUCYK SN
    Acute Cardiovascular Toxicity of Cocaine.
    Can J Cardiol. 2022;38:1384-1394.
    PubMed     Abstract available
    
    
    
96. D'ENTREMONT MA, Couture EL, Connelly K, Walling A, et al
    Management of the Master Endurance Athlete With Stable Coronary Artery Disease.
    Can J Cardiol. 2022;38:1450-1453.
    PubMed    
    
    
    
97. GAGNON LR, Sadasivan C, Perera K, Oudit GY, et al
    Cardiac Complications of Common Drugs of Abuse: Pharmacology, Toxicology, and Management.
    Can J Cardiol. 2022;38:1331-1341.
    PubMed     Abstract available
    
    
    August 2022
98. TERADA T, Cotie LM, Tulloch H, Mistura M, et al
    Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    Can J Cardiol. 2022;38:1235-1243.
    PubMed     Abstract available
    
    
    
99. THOMPSON CR
    Acute Coronary Syndrome and Aortic Stenosis: A Lethal Combo!
    Can J Cardiol. 2022;38:1130-1131.
    PubMed    
    
    
    
100. PARLOW S, Weng W, Di Santo P, Jung RG, et al
     Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
     Can J Cardiol. 2022;38:1211-1219.
     PubMed     Abstract available
     
     
     
101. CHEW NWS, Zhang A, Ong J, Koh S, et al
     Long-term Prognosis in Patients With Concomitant Acute Coronary Syndrome and Aortic Stenosis.
     Can J Cardiol. 2022;38:1220-1227.
     PubMed     Abstract available
     
     
     
102. TEHRANI BN, Drakos SG, Billia F, Batchelor WB, et al
     The Multicenter Collaborative to Enhance Biologic Understanding, Quality, and Outcomes in Cardiogenic Shock (VANQUISH Shock): Rationale and Design.
     Can J Cardiol. 2022;38:1286-1295.
     PubMed     Abstract available
     
     
     
103. RAO K, Granger E, Dvir D, Fahmy P, et al
     BASILICA Technique for Prevention of Coronary Artery Occlusion in High-Risk Native Transcatheter Aortic Valve Replacement.
     Can J Cardiol. 2022;38:1312-1314.
     PubMed    
     
     
     July 2022
104. RAPARELLI V, Wright CX, Corica B, Sharma G, et al
     Interventions Targeted to Address Social Determinants of Health in Ischemic Heart Disease: A Sex- and Gender-Oriented Scoping Review.
     Can J Cardiol. 2022 Jul 6. pii: S0828-282X(22)00405.
     PubMed     Abstract available
     
     
     June 2022
105. LEUNG AA, Anderson TJ
     PCSK9 Inhibition Following Myocardial Infarction: A Right Time to Act.
     Can J Cardiol. 2022 Jun 23. pii: S0828-282X(22)00393.
     PubMed    
     
     
     
106. PIVATO CA, Jones D, Cao D, Sartori S, et al
     Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention.
     Can J Cardiol. 2022;38:792-800.
     PubMed     Abstract available
     
     
     
107. GNANENTHIRAN SR, Ng ACC, Cumming RG, Brieger DB, et al
     Hemoglobin, Frailty, and Long-term Cardiovascular Events in Community-Dwelling Older Men Aged >/= 70 Years.
     Can J Cardiol. 2022;38:745-753.
     PubMed     Abstract available
     
     
     May 2022
108. CHIANG CE, Schwartz GG, Elbez Y, Szarek M, et al
     Alirocumab and Cardiovascular Outcomes in Patients with Previous Myocardial Infarction: Prespecified Sub-analysis from ODYSSEY OUTCOMES.
     Can J Cardiol. 2022 May 26. pii: S0828-282X(22)00337.
     PubMed     Abstract available
     
     
     
109. CHAHDI HO, Berbach L, Boivin-Proulx LA, Hillani A, et al
     Percutaneous Mechanical Circulatory Support in Post-Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis.
     Can J Cardiol. 2022 May 25. pii: S0828-282X(22)00333.
     PubMed     Abstract available
     
     
     April 2022
110. MIDDLEKAUFF HR, Cooper ZD, Strauss SB
     Drugs of Misuse: Focus on Vascular Dysfunction.
     Can J Cardiol. 2022 Apr 21. pii: S0828-282X(22)00261.
     PubMed     Abstract available
     
     
     March 2022
111. PERRIN N, Avram R
     Invasive Management of Refractory Angina: Are We There Yet?
     Can J Cardiol. 2022;38:306-308.
     PubMed    
     
     
     
112. HOCHSTADT A, Itach T, Merdler I, Ghantous E, et al
     Effectiveness of Coronary Sinus Reducer for Treatment of Refractory Angina: A Meta-analysis.
     Can J Cardiol. 2022;38:376-383.
     PubMed     Abstract available
     
     
     
113. BOUCHER T, Shah AM, Hashim H, Jerschow E, et al
     Durable Polymer Drug Eluting Stent-Induced Kounis Syndrome and Eosinophilia Requiring Long-term Immunosuppression.
     Can J Cardiol. 2022;38:398-400.
     PubMed    
     
     
     
114. EMAMI M, Agbaedeng TA, Thomas G, Middeldorp ME, et al
     Accelerated Biological Aging Secondary to Cardiometabolic Risk Factors Is a Predictor of Cardiovascular Mortality: A Systematic Review and Meta-analysis.
     Can J Cardiol. 2022;38:365-375.
     PubMed     Abstract available
     
     
     February 2022
115. MALHI N, Moghaddam N, Hosseini F, Singer J, et al
     Care and Outcomes of ST-Segment-Elevation Myocardial Infarction across multiple Coronavirus Disease 2019 (COVID-19) waves.
     Can J Cardiol. 2022 Feb 10. pii: S0828-282X(22)00089.
     PubMed     Abstract available
     
     
     January 2022
116. BOITARD SE, Keck M, Deloux R, Girault-Sotias PE, et al
     QGC606, a best-in-class orally active centrally acting aminopeptidase A inhibitor prodrug, for treating heart failure following myocardial infarction.
     Can J Cardiol. 2022 Jan 25. pii: S0828-282X(22)00069.
     PubMed     Abstract available
     
     
     
117. CHAVARRIA J, Sibbald M, Velianou J, Natarajan M, et al
     A Computed Tomography Protocol to Evaluate Coronary Artery Disease Before Transcatheter Aortic Valve Replacement.
     Can J Cardiol. 2022;38:23-30.
     PubMed     Abstract available
     
     
     
118. TANG H, Li Z, Fan Y, Zhang T, et al
     Differences in Culprit Lesions Between Premenopausal and Postmenopausal Women With Acute Coronary Syndrome: An Optical Coherence Tomography Study.
     Can J Cardiol. 2022;38:85-91.
     PubMed     Abstract available
     
     
     
119. LEBOUTTE PH, Demers P, Joubert P, Marquis-Gravel G, et al
     Percutaneous Management of Septic Left Anterior Descending Coronary Occlusion Following Minimally Invasive Surgery for Mitral Valve Infective Endocarditis.
     Can J Cardiol. 2022;38:126-128.
     PubMed     Abstract available
     
     
     
120. GALLONE G, Baldetti L, Angelini F, Saglietto A, et al
     The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials.
     Can J Cardiol. 2022;38:113-122.
     PubMed     Abstract available
     
     
     December 2021
121. DEL MONTE A, Marra MP, Cardaioli F, Gerosa G, et al
     Two left ventricular pseudoaneurysms complicating a myocardial infarction. The impact of cardiac magnetic resonance in the acute setting.
     Can J Cardiol. 2021 Dec 6. pii: S0828-282X(21)00918.
     PubMed     Abstract available
     
     
     
122. SAMUEL R, Alfadhel M, McAlister C, Nestelberger T, et al
     Coronary Events in the Pregnant Patient: Who Is at Risk and How Best to Manage?
     Can J Cardiol. 2021;37:2026-2034.
     PubMed     Abstract available
     
     
     
123. ZEN M, Marschner S, Szczeklik W, Roshanov PS, et al
     Association of Preeclampsia With Myocardial Injury Among Patients Undergoing Noncardiac Surgery: The PREECLAMPSIA-VISION Study.
     Can J Cardiol. 2021;37:1934-1941.
     PubMed     Abstract available
     
     
     November 2021
124. LEE M, Lee K, Kim DW, Cho JS, et al
     Relationship of serial hsCRP changes to long-term clinical outcomes in stabilized post myocardial infarction patients.
     Can J Cardiol. 2021 Nov 1. pii: S0828-282X(21)00808.
     PubMed     Abstract available
     
     
     
125. LEASURE M, Jain U, Butchy A, Otten J, et al
     Deep Learning Algorithm Predicts Angiographic Coronary Artery Disease in Stable Patients Using Only a Standard 12-Lead Electrocardiogram.
     Can J Cardiol. 2021;37:1715-1724.
     PubMed     Abstract available
     
     
     
126. MARQUIS-GRAVEL G, Goodman SG, Anderson TJ, Bell AD, et al
     Colchicine for Prevention of Atherothrombotic Events in Patients With Coronary Artery Disease: Review and Practical Approach for Clinicians.
     Can J Cardiol. 2021;37:1837-1845.
     PubMed     Abstract available
     
     
     
127. MURAI K, Otsuka F, Yoneda S, Kataoka Y, et al
     Temporal Changes in Near-Infrared Spectroscopy Signals in Recurrent In-Stent Restenosis Attributable to Calcified Nodule.
     Can J Cardiol. 2021;37:1880-1881.
     PubMed    
     
     
     October 2021
128. BLUSZTEIN D, Teng P, Deuse T, Mahadevan VS, et al
     Shock, Thrombus, TAVR: A Challenging TAVR With Large Left-Ventricular Thrombus.
     Can J Cardiol. 2021;37:1668-1670.
     PubMed     Abstract available
     
     
     
129. GOSLING RC, Adam Z, Barmby DS, Iqbal J, et al
     The Impact of Virtual Fractional Flow Reserve and Virtual Coronary Intervention on Treatment Decisions in the Cardiac Catheter Laboratory.
     Can J Cardiol. 2021;37:1530-1538.
     PubMed     Abstract available
     
     
     
130. KOO CY, Lim AYN, Chan KH
     Recurrent Stent Thrombosis Secondary to Immunoglobulin G4-Related Disease.
     Can J Cardiol. 2021;37:1659-1660.
     PubMed     Abstract available
     
     
     
131. LUO T, Liu H, Chen B, Liu H, et al
     A Novel Role of Claudin-5 in Prevention of Mitochondrial Fission Against Ischemic/Hypoxic Stress in Cardiomyocytes.
     Can J Cardiol. 2021;37:1593-1606.
     PubMed     Abstract available
     
     
     
132. JOLICOEUR EM, Pelletier-Galarneau M
     Rubidium-82 Positron Emission Tomography With Intravenous Ergonovine to Diagnose Vasospastic Angina.
     Can J Cardiol. 2021;37:1661-1664.
     PubMed     Abstract available
     
     
     September 2021
133. CHEW NWS, Ow ZGW, Teo VXY, Heng RRY, et al
     The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis.
     Can J Cardiol. 2021;37:1450-1459.
     PubMed     Abstract available
     
     
     
134. MASTERSON CREBER R, Spadaccio C, Dimagli A, Myers A, et al
     Patient-Reported Outcomes in Cardiovascular Trials.
     Can J Cardiol. 2021;37:1340-1352.
     PubMed     Abstract available
     
     
     August 2021
135. VIKULOVA DN, Trinder M, Mancini GBJ, Pimstone SN, et al
     Familial Hypercholesterolemia, Familial Combined Hyperlipidemia and Elevated Lipoprotein(a) in Patients with Premature Coronary Artery Disease.
     Can J Cardiol. 2021 Aug 26. pii: S0828-282X(21)00657.
     PubMed     Abstract available
     
     
     
136. ROSHANOV PS, Sessler DI, Chow CK, Garg AX, et al
     Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study.
     Can J Cardiol. 2021;37:1215-1224.
     PubMed     Abstract available
     
     
     
137. MARIUCCI E, Bonori L, Lovato L, Graziano C, et al
     Coronary Artery Aneurysms in Patients With Marfan Syndrome: Frequent, Progressive, and Relevant.
     Can J Cardiol. 2021;37:1225-1231.
     PubMed     Abstract available
     
     
     
138. CHIU S, Nayak R, Lin B, Duan L, et al
     Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome.
     Can J Cardiol. 2021;37:1191-1197.
     PubMed     Abstract available
     
     
     
139. ABOUKHOUDIR F, Najjar A, Moussa K, Habib G, et al
     A Thrombus on a Journey: A Massive Thrombus in Transit With Cerebral, Coronary, and Pulmonary Embolization.
     Can J Cardiol. 2021;37:1281-1282.
     PubMed     Abstract available
     
     
     July 2021
140. HADJADJ S, Marsit O, Paradis JM, Beaudoin J, et al
     Pathophysiology, Diagnosis, and New Therapeutic Approaches for Ischemic Mitral Regurgitation.
     Can J Cardiol. 2021;37:968-979.
     PubMed     Abstract available
     
     
     June 2021
141. XIE Y, Seidman MA
     Inflammatory Comments in Coronary Artery Disease: When to Suspect Polyarteritis Nodosa or Other Primary Systemic Vasculitis.
     Can J Cardiol. 2021;37:830-832.
     PubMed    
     
     
     
142. LAI J, Zhao L, Zhong H, Zhou J, et al
     Characteristics and Outcomes of Coronary Artery Involvement in Polyarteritis Nodosa.
     Can J Cardiol. 2021;37:895-903.
     PubMed     Abstract available
     
     
     
143. MA K, Qi L, Yuan J, Zhang B, et al
     Anatomic Repair of Left Main Coronary Artery Atresia: Coronary Ostioplasty With Autologous Pulmonary Artery.
     Can J Cardiol. 2021;37:887-894.
     PubMed     Abstract available
     
     
     April 2021
144. WELSH RC, Cantor WJ, Traboulsi M, Schampaert E, et al
     Primary Percutaneous Coronary Intervention and Application of the Pharmacoinvasive Approach Within ST-Elevation Myocardial Infarction Care Networks: CJC Supplement - 40 Years of Innovation in Interventional Cardiology in Canada.
     Can J Cardiol. 2021 Apr 7. pii: S0828-282X(21)00173.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.